Thermo Fisher Scientific KMT2E Polyclonal Antibody

Applications and Tested Dilutions

Product Specifications

Product Specific Information

• Positive Samples: NCI-H460, 293T, Mouse brain
• Immunogen sequence:
  VELYTAFQHT PTSITLTASR VSKVNDKRRK KSGEKEQHIS KCKKAFREGS RKSSRVKGSA PEIDPSSDGS NFGWETKIKA WMDRYEEANN NQYSEGVQRE AQRIALRLGN GNDKKEMNKS DLNTNNLLFK PPVESHIQKN KKILKSAKDL PPDALIIEYR GKFMLREQFE ANGYFFKRPY PFVLFYSKFH GLEMCVDART FGNEARFIRR SCTPNAEVRH EIQDGTIHLY IYSIHSIPKG TEITIAFDFD YGNCKYKVDC ACLKENPECP VLKRSSESME NINSGYETRR KKGKKDKDIS K

Target Information

The mixed lineage leukemia (MLL) gene family comprises a group of Histone H3 lysine 4 (H3K4) methyltransferases within the larger SET1 family.
The founding member MLL commonly undergoes translocations in infantile leukemia and displays increased expression in some adult myeloid leukemias.
MLL2 (also designated ALR) exists within a complex of proteins and is important for mouse embryonic development, potentially involved in adhesion-related cytoskeletal events affecting cell growth and survival.
The MLL2 gene maps to human locus 19q13.1, a frequent target of rearrangement or amplification in solid tumors.
MLL3 or its paralogue MLL4 associate with activating signal cointegrator-2 (ASC-2), regulating ligand-dependent H3K4 trimethylation and expression of LXR-target genes.
MLL3 maps to human chromosome 7, often deleted in myeloid disorders, and exhibits higher expression in peripheral blood, placenta, pancreas, testis, and fetal thymus.
MLL5 localizes to the nucleus and forms intranuclear protein complexes, potentially regulating chromatin remodeling and cellular growth suppression.
The gene encoding human MLL5 lies within chromosome band 7q22.3, a region deleted in cytogenetic aberrations of acute myeloid malignancies.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.